{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T07:51:00Z","timestamp":1790409060852,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.amjmed.2009.03.026","type":"journal-article","created":{"date-parts":[[2009,8,27]],"date-time":"2009-08-27T02:28:25Z","timestamp":1251340105000},"page":"919-930","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Incidence of Thrombocytopenia in Hospitalized Patients with Venous Thromboembolism"],"prefix":"10.1016","volume":"122","author":[{"given":"Paul D.","family":"Stein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell D.","family":"Hull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadi","family":"Matta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdo Y.","family":"Yaekoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5 Suppl","key":"10.1016\/j.amjmed.2009.03.026_bib1","doi-asserted-by":"crossref","first-page":"489S","DOI":"10.1378\/chest.114.5_Supplement.489S","article-title":"considerations, monitoring, efficacy, and safety","volume":"114","author":"Hirsh","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.amjmed.2009.03.026_bib4","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1158\/0008-5472.CAN-06-4303","article-title":"Chemotherapy-induced thrombocytopenia derives from the selective death of megakaryocyte progenitors and can be rescued by stem cell factor","volume":"67","author":"Zeuner","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.amjmed.2009.03.026_bib5","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1161\/01.CIR.95.5.1242","article-title":"Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery","volume":"95","author":"Bauer","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.amjmed.2009.03.026_bib6","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1001\/archinte.163.20.2518","article-title":"An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients","volume":"163","author":"Warkentin","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjmed.2009.03.026_bib7","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1046\/j.1365-2141.2002.03687.x","article-title":"Incidence and clinical relevance of heparin-induced antibodies in patients with deep vein thrombosis treated with unfractionated or low-molecular-weight heparin","volume":"118","author":"Lindhoff-Last","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.amjmed.2009.03.026_bib8","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1001\/archinternmed.2007.65","article-title":"Incidence and prognostic significance of thrombocytopenia in patients treated with prolonged heparin therapy","volume":"168","author":"Oliveira","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjmed.2009.03.026_bib9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ccl.2007.12.009","article-title":"Heparins, low-molecular-weight heparins, and pentasaccharides: use in the older patient","volume":"26","author":"Dinwoodey","year":"2008","journal-title":"Cardiol Clin"},{"key":"10.1016\/j.amjmed.2009.03.026_bib10","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1182\/blood-2005-04-1546","article-title":"Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis","volume":"106","author":"Martel","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.amjmed.2009.03.026_bib11","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1378\/chest.06-2518","article-title":"No difference in risk for thrombocytopenia during treatment of pulmonary embolism and deep venous thrombosis with either low-molecular-weight heparin or unfractionated heparin: a meta-analysis","volume":"132","author":"Morris","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.amjmed.2009.03.026_bib12","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1056\/NEJM199709043371002","article-title":"A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism","volume":"337","author":"Simonneau","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2009.03.026_bib13","doi-asserted-by":"crossref","first-page":"191","DOI":"10.7326\/0003-4819-134-3-200102060-00009","article-title":"Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease","volume":"134","author":"Merli","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjmed.2009.03.026_bib14","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1001\/archinte.164.10.1077","article-title":"Subcutaneous adjusted-dose unfractionated heparin vs fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism","volume":"164","author":"Prandoni","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjmed.2009.03.026_bib15","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0002-9610(99)80222-0","article-title":"A comparative trial of a low molecular weight heparin (enoxaparin) versus standard heparin for the prophylaxis of postoperative deep vein thrombosis in general surgery","volume":"169","author":"Nurmohamed","year":"1995","journal-title":"Am J Surg"},{"key":"10.1016\/j.amjmed.2009.03.026_bib16","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/BF00443477","article-title":"Prevention of deep vein thrombosis with low molecular-weight heparin in patients undergoing total hip replacement","volume":"111","year":"1992","journal-title":"Arch Orthop Trauma Surg"},{"key":"10.1016\/j.amjmed.2009.03.026_bib17","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1055\/s-2008-1036089","article-title":"Prevention of thrombosis in gynecology: double-blind comparison of low molecular weight heparin and unfractionated heparin","volume":"49","author":"Heilmann","year":"1989","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"10.1016\/j.amjmed.2009.03.026_bib18","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJM199909093411103","article-title":"A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients","volume":"341","author":"Samama","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2009.03.026_bib19","first-page":"567","article-title":"Calcium nadroparin in the prevention of thromboembolic disease in elderly subjects","volume":"24","author":"Forette","year":"1995","journal-title":"Presse Med"},{"key":"10.1016\/j.amjmed.2009.03.026_bib20","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1001\/archinte.1989.00390060039008","article-title":"Low incidence of thrombocytopenia with porcine mucosal heparin","volume":"149","author":"Rao","year":"1989","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjmed.2009.03.026_bib21","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/01.CIR.0000138928.83266.24","article-title":"Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients","volume":"110","author":"Leizorovicz","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.amjmed.2009.03.026_bib22","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1182\/blood-2005-03-0912","article-title":"The incidence of heparin-induced thrombocytopenia in medical patients treated with low-molecular-weight heparin: a prospective cohort study","volume":"106","author":"Prandoni","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.amjmed.2009.03.026_bib23","doi-asserted-by":"crossref","first-page":"858","DOI":"10.7326\/0003-4819-135-10-200111200-00006","article-title":"Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review","volume":"135","author":"Hull","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjmed.2009.03.026_bib24","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1182\/blood-2002-07-2201","article-title":"The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study","volume":"101","author":"Girolami","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.amjmed.2009.03.026_bib25","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa035451","article-title":"Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism","volume":"349","author":"B\u00fcller","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2009.03.026_bib26","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1001\/jama.1979.03290480030018","article-title":"Thrombocytopenia found uncommonly during heparin therapy","volume":"241","author":"Powers","year":"1979","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2009.03.026_bib27","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1055\/s-0038-1650013","article-title":"Heparin induced thrombocytopenia: a prospective study","volume":"43","author":"Ansell","year":"1980","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.amjmed.2009.03.026_bib28","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1378\/chest.88.6.878","article-title":"Heparin-induced thrombocytopenia","volume":"88","author":"Ansell","year":"1985","journal-title":"Chest"},{"key":"10.1016\/j.amjmed.2009.03.026_bib29","first-page":"374","article-title":"Heparin-associated thrombocytopenia: a prospective comparison of bovine lung heparin, manufactured by a new process, and porcine intestinal heparin","volume":"20","author":"Bailey","year":"1986","journal-title":"Drug Intell Clin Pharm"},{"key":"10.1016\/j.amjmed.2009.03.026_bib30","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1056\/NEJM198010163031602","article-title":"Heparin-associated thrombocytopenia: a comparison of three heparin preparations","volume":"303","author":"Bell","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2009.03.026_bib31","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/00007691-198306000-00010","article-title":"Heparin-associated thrombocytopenia: a prospective evaluation of 211 patients","volume":"5","author":"Cipolle","year":"1983","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.amjmed.2009.03.026_bib32","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/00000441-198409000-00003","article-title":"Thrombocytopenia in a prospective, randomized, double-blind trial of bovine and porcine heparin","volume":"288","author":"Green","year":"1984","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.amjmed.2009.03.026_bib33","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0049-3848(84)90083-5","article-title":"Studies on the frequency of heparin-associated thrombocytopenia","volume":"33","author":"Powers","year":"1984","journal-title":"Thromb Res"},{"key":"10.1016\/j.amjmed.2009.03.026_bib34","doi-asserted-by":"crossref","first-page":"W1","DOI":"10.7326\/0003-4819-138-1-200301070-00012-w1","article-title":"The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration","volume":"138","author":"Bossuyt","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjmed.2009.03.026_bib35","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00005650-199401000-00006","article-title":"Bias in the coding of hospital discharge data and its implications for quality assessment","volume":"32","author":"Romano","year":"1994","journal-title":"Med Care"},{"key":"10.1016\/j.amjmed.2009.03.026_bib36","doi-asserted-by":"crossref","first-page":"737","DOI":"10.7326\/0003-4819-128-9-199805010-00006","article-title":"Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California","volume":"128","author":"White","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjmed.2009.03.026_bib37","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1001\/archinte.1994.00420080053005","article-title":"The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly","volume":"154","author":"Kniffin","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjmed.2009.03.026_bib38","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.amjmed.2003.11.020","article-title":"Pulmonary thromboembolism in Asian\/Pacific Islanders in the United States: Analysis of data from the National Hospital Discharge Survey and the United States Bureau of the Census","volume":"116","author":"Stein","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.amjmed.2009.03.026_bib39","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/096721099700500114","article-title":"Pulmonary embolism: diagnosis, incidence, and implications","volume":"5","author":"Proctor","year":"1997","journal-title":"Cardiovasc Surg"},{"key":"10.1016\/j.amjmed.2009.03.026_bib40","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1378\/chest.108.4.978","article-title":"Prevalence of acute pulmonary embolism in a general hospital and at autopsy","volume":"108","author":"Stein","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.amjmed.2009.03.026_bib41","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1378\/chest.121.3.802","article-title":"Estimated incidence of acute pulmonary embolism in a community\/teaching general hospital","volume":"121","author":"Stein","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.amjmed.2009.03.026_bib42","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1056\/NEJM198802113180604","article-title":"Accuracy of diagnostic coding for medicare patients under the prospective payment system","volume":"318","author":"Hsia","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2009.03.026_bib43","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1034\/j.1600-0404.2002.01215.x","article-title":"Enoxaparin vs heparin for prevention of deep-vein thrombosis in acute ischaemic stroke: a randomized, double-blind study","volume":"106","author":"Hillbom","year":"2002","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.amjmed.2009.03.026_bib44","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2106\/00004623-199401000-00002","article-title":"Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement","volume":"76","author":"Colwell","year":"1994","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.amjmed.2009.03.026_bib45","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1055\/s-2008-1037391","article-title":"Potentials risks in drug prevention of thrombosis\u2014low-molecular-weight heparin versus standard heparin","volume":"137","author":"Ganzer","year":"1999","journal-title":"Z Orthop Ihre Grenzgeb"},{"key":"10.1016\/j.amjmed.2009.03.026_bib46","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1182\/blood-2005-05-1824","article-title":"Replacement of unfractionated heparin by low-molecular-weight heparin for postorthopedic surgery antithrombotic prophylaxis lowers the overall risk of symptomatic thrombosis because of a lower frequency of heparin-induced thrombocytopenia","volume":"106","author":"Greinacher","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.amjmed.2009.03.026_bib47","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/00000658-200103000-00020","article-title":"Subcutaneous heparin versus low-molecular-weight heparin as thromboprophylaxis in patients undergoing colorectal surgery: results of the Canadian colorectal DVT prophylaxis trial: a randomized, double-blind trial","volume":"233","author":"McLeod","year":"2001","journal-title":"Ann Surg"},{"key":"10.1016\/j.amjmed.2009.03.026_bib48","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1136\/bmj.303.6802.543","article-title":"Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin","volume":"303","author":"Leyvraz","year":"1991","journal-title":"BMJ"},{"key":"10.1016\/j.amjmed.2009.03.026_bib49","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00113-001-0345-8","article-title":"Heparin-induced thrombocytopenia as a complication of postoperative prevention of thromboembolism with unfractionated heparin\/low molecular weight heparin after hip and knee prosthesis implantation","volume":"105","author":"Mahlfeld","year":"2002","journal-title":"Unfallchirurg"},{"key":"10.1016\/j.amjmed.2009.03.026_bib50","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199505183322003","article-title":"Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin","volume":"332","author":"Warkentin","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2009.03.026_bib51","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-0038-1650553","article-title":"Once-daily subcutaneous dalteparin, a low molecular weight heparin, for the initial treatment of acute deep vein thrombosis","volume":"76","author":"Fiessinger","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.amjmed.2009.03.026_bib52","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1056\/NEJM199603143341102","article-title":"Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home","volume":"334","author":"Koopman","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2009.03.026_bib53","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1055\/s-0037-1613886","article-title":"Fixed-dose, body weight-independent subcutaneous LMW heparin versus adjusted dose unfractionated intravenous heparin in the initial treatment of proximal venous thrombosis","volume":"83","author":"Harenberg","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.amjmed.2009.03.026_bib54","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1056\/NEJM199603143341101","article-title":"A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis","volume":"334","author":"Levine","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2009.03.026_bib55","first-page":"135","article-title":"Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis","volume":"17","author":"Kirchmaier","year":"1998","journal-title":"Int Angiol"},{"key":"10.1016\/j.amjmed.2009.03.026_bib56","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1067\/mob.2001.114690","article-title":"Heparin-induced thrombocytopenia is rare in pregnancy","volume":"185","author":"Fausett","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.amjmed.2009.03.026_bib57","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1055\/s-0037-1614550","article-title":"Safety of low-molecular-weight heparin in pregnancy: a systematic review","volume":"81","author":"Sanson","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.amjmed.2009.03.026_bib58","first-page":"1134","article-title":"Venous thromboembolism during pregnancy: a retrospective study of enoxaparin safety in 624 pregnancies","volume":"108","author":"Lepercq","year":"2001","journal-title":"BJOG"},{"issue":"Suppl 3","key":"10.1016\/j.amjmed.2009.03.026_bib59","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.1007\/PL00014338","article-title":"Heparin-induced thrombocytopenia in paediatric patients\u2014a review of the literature and a new case treated with danaparoid sodium","volume":"158","author":"Ranze","year":"1999","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.amjmed.2009.03.026_bib60","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1160\/TH03-09-0571","article-title":"Heparin-induced thrombocytopenia in children: 12 new cases and review of the literature","volume":"91","author":"Klenner","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.amjmed.2009.03.026_bib61","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1182\/blood-2005-11-012450","article-title":"Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia","volume":"108","author":"Warkentin","year":"2006","journal-title":"Blood"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934309004379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934309004379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T08:51:22Z","timestamp":1757580682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934309004379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":59,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0002934309004379"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2009.03.026","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence of Thrombocytopenia in Hospitalized Patients with Venous Thromboembolism","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2009.03.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}